CNA Financial Corporation (CNA)
NYSE: CNA
· Real-Time Price · USD
47.63
-0.53 (-1.10%)
At close: May 01, 2025, 2:33 PM
CNA Financial Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Commercial Segment Revenue | 1.51B | 1.43B | 1.39B | 1.33B | 1.29B | 1.2B | 1.17B | 1.15B | 1.09B | 1.03B | 1.09B | 1.04B | 1.06B | 1.01B | 1.04B | 1.03B |
| Commercial Segment Revenue Growth | +5.66% | +3.32% | +3.82% | +3.41% | +7.40% | +2.56% | +2.09% | +5.22% | +5.92% | -5.50% | +4.71% | -1.79% | +5.16% | -2.70% | +0.78% | n/a |
| International Segment Revenue | 343M | 343M | 346M | 321M | 328M | 313M | 287M | 286M | 284M | 277M | 282M | 285M | 281M | 266M | 255M | 251M |
| International Segment Revenue Growth | 0.00% | -0.87% | +7.79% | -2.13% | +4.79% | +9.06% | +0.35% | +0.70% | +2.53% | -1.77% | -1.05% | +1.42% | +5.64% | +4.31% | +1.59% | n/a |
| Life and Group Non-Core Segment Revenue | 350M | 348M | 341M | 328M | 342M | 329M | 320M | 305M | 320M | 331M | 365M | 362M | 390M | 340M | 1.22B | 1.18B |
| Life and Group Non-Core Segment Revenue Growth | +0.57% | +2.05% | +3.96% | -4.09% | +3.95% | +2.81% | +4.92% | -4.69% | -3.32% | -9.32% | +0.83% | -7.18% | +14.71% | -72.11% | +3.57% | n/a |
| Specialty Segment Revenue | 1.41B | 1.39B | 1.37B | 1.37B | 1.36B | 1.33B | 1.35B | 1.31B | 1.29B | 1.26B | 1.31B | 1.25B | 1.25B | 1.19B | n/a | n/a |
| Specialty Segment Revenue Growth | +1.37% | +1.17% | 0.00% | +0.81% | +2.10% | -1.62% | +3.44% | +1.87% | +2.23% | -4.12% | +5.21% | -0.64% | +5.46% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|
| Specialty Segment Revenue | 5.49B | 1.79B | 1.62B | 1.41B |
| Specialty Segment Revenue Growth | +207.39% | +9.98% | +15.01% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |